This page was translated automatically from Turkish. Read the original

This page is an AI-assisted Turkish summary of the study presented at the 26th World Congress of Psychiatry. The study belongs to the presenting authors; please refer to the original source when citing it.

EV0347

Internet-delivered cognitive behavioral therapy for childhood asthma-related anxiety: a feasibility study

INTERNET-DELIVERED COGNITIVE BEHAVIOR THERAPY FOR ANXIETY RELATED TO PEDIATRIC ASTHMA: A FEASIBILITY TRIAL

Internet-delivered cognitive behavioral therapy for children and adolescents with asthma and their parents was found to be acceptable and feasible, with preliminary analyses showing a reduction in asthma-related anxiety.

The aim was to evaluate a new internet-delivered cognitive behavioral therapy (ICBT) program for children and adolescents with asthma-related anxiety and their parents. Twenty-seven Swedish children and adolescents (aged 8 to 17 years) and their parents received 8 weeks of ICBT with asynchronous therapist support; eligibility required physician-diagnosed asthma and asthma-related anxiety and/or functional impairment. Baseline characteristics (N = 27): mean age 11.78 years (SD 2.06), range 8 to 15 years; 15 girls (56%); mean asthma duration 5.33 years (SD 3.58), range 1 to 11 years; allergies in 18 participants (67%); a psychiatric disorder identified using the M.I.N.I. KID in 12 participants (44%); and 24 mothers (89%) among actively participating parents. Total scores on the Pediatric Quality of Life Inventory Asthma Module (PedsQL Asthma Module, range 0 to 100; higher scores indicate a lower perceived symptom burden) improved significantly from pretreatment to posttreatment in both children and adolescents and parents (p < 0.05 for both). Feasibility, acceptability, satisfaction, and therapeutic alliance scores indicated good intervention uptake and user experience; participants completed an average of 5.59 of the 8 modules (children and adolescents) and 6.04 modules (parents), and no serious adverse events were reported. The results are based on preliminary pretreatment and posttreatment analyses; the primary endpoint will be assessed at the 2-month follow-up, and validation of the measurement instruments is ongoing to inform the subsequent randomized controlled trial.

All WCP 2026 summaries